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Abstract
Ensemble Modeling (EM) is a recently developed method for metabolic modeling, particularly for utilizing the effect of
enzyme tuning data on the production of a specific compound to refine the model. This approach is used here to
investigate the production of aromatic products in Escherichia coli. Instead of using dynamic metabolite data to fit a model,
the EM approach uses phenotypic data (effects of enzyme overexpression or knockouts on the steady state production rate)
to screen possible models. These data are routinely generated during strain design. An ensemble of models is constructed
that all reach the same steady state and are based on the same mechanistic framework at the elementary reaction level. The
behavior of the models spans the kinetics allowable by thermodynamics. Then by using existing data from the literature for
the overexpression of genes coding for transketolase (Tkt), transaldolase (Tal), and phosphoenolpyruvate synthase (Pps) to
screen the ensemble, we arrive at a set of models that properly describes the known enzyme overexpression phenotypes.
This subset of models becomes more predictive as additional data are used to refine the models. The final ensemble of
models demonstrates the characteristic of the cell that Tkt is the first rate controlling step, and correctly predicts that only
after Tkt is overexpressed does an increase in Pps increase the production rate of aromatics. This work demonstrates that
EM is able to capture the result of enzyme overexpression on aromatic producing bacteria by successfully utilizing routinely
generated enzyme tuning data to guide model learning.
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Introduction
The manipulation of the enzymatic reactions which make up
metabolic networks is at the heart of metabolic engineering.
However, due to the complex and highly-interconnected nature of
these networks, it is sometimes not a trivial process to understand
what the effect of an enzymatic perturbation will be, or vice versa,
what enzymatic perturbations are necessary to yield a desired
effect. Flux distribution is often controlled by multiple enzymes in
the network [1–10], indirectly linked to the pathways of interest.
Thus, it is desirable to develop mathematical models to describe,
understand, and predict network behavior. Through the develop-
ment of such models, one gains the ability to generate a set of
testable hypotheses for system behavior.
In typical kinetic modeling, kinetic parameters are determined
in order to best fit the time-dependent metabolite concentration
data obtained from experiment, using a wide variety of kinetic rate
expressions. However, these types of data are rare and are not
commonly generated in a typical strain improvement process. On
the other hand, enzyme overexpressions or knockouts are
commonly used in strain development, and the effects of enzyme
expression tuning on product formation or substrate consumption
are the typical readouts. To our knowledge, such data are difficult
to incorporate into modeling, particularly when the results are
semi-quantitative, since the fold-changes of enzyme overexpression
are rarely measured.
Recently, the Ensemble Modeling (EM) approach was developed
for the modeling of metabolic networks [11–13]. The detailed EM
framework has been previously published [11], but few biological
examples were used as validation. EM has been used to study a real
biological example for the production of lysine [13], and EM has
been compared to other modeling methodologies in more detail
[12]. In this approach, rather than focusing on the development of a
kinetic model that fits the dynamic metabolite concentration data,
we seek to utilize data that captures the effect of enzyme tuning on
the steady state production flux to guide model development. This
typeof data is not typically utilized in modeling endeavors, and does
not result in a change in the stoichiometry of the network. However,
the effect that an enzyme’s overexpression has on the system’s
steady state flux can unveil some knowledge regarding how control
over the flux is distributed throughout the metabolic network, and
can thus be used to aid in model development. EM is related to the
insightful application of Metabolic Control Analysis (MCA) to
metabolic systems with uncertain kinetic parameters in that a
random sampling of kinetics was used for analysis [14,15].
However, EM does not require the MCA relationships which are
derived based on a linearized system. Other uses of sampling in
metabolic analyses was reviewed previously [16].
In EM, initially, an ensemble of models that all reach the
reference steady state in terms of flux distribution is constructed.
These models span the space of kinetics allowable by thermody-
namic constraints, and are based on elementary reactions, which
are the most fundamental and general kinetic descriptions for
enzymatic reactions [6,17]. EM describes the kinetics using a set of
elementary reactions, as shown in Figure 1, which can be
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requires mass-action kinetics for the reactions, which is not valid if
enzyme concentrations are not explicitly considered. However,
through the use of elementary reactions at the enzyme level, the
log-linear transformation can be completed, while still preserving
the intrinsic non-linear behavior in enzyme kinetics, thus
preserving the true biological mechanism and benefiting from
the mathematical tractability. This framework does not rely on a
local linearization of the system, and one is free to perform and
determine the effect of large perturbations on the network. In lieu
of dynamic metabolite data, which can be difficult to obtain, the
EM approach uses phenotypic data to screen possible models.
Phenotypic data can include the effects of enzyme overexpressions
or knockouts on the production rate of any products or
byproducts. Such data are routinely generated in strain design
efforts. Through this approach, one does not attempt to acquire
detailed kinetic parameters that fit the time-dependent metabolite
data, but rather capture phenotypes that are dependent on
changes in the enzyme levels in the network. Also important is the
ability of EM to be driven by the goal of, and ability to, learn from
experimental results regarding the phenotypes obtained by
enzyme perturbations. Rather than assessing the control properties
of the system, or fitting dynamic metabolite concentrations, the
focus of EM is to rely on existing experimental data to drive strain
design. Through this knowledge feedback loop, we can further
constrain our subset of models and thus refine our predictions of
system behavior. The algorithm for EM is illustrated in Figure 2.
In this work, we implement the EM approach to the production
of aromatic amino acids in Escherichia coli. Aromatic compounds
are of substantial industrial importance, with many uses and high
rates of production, including the aromatic amino acids and other
derived compounds such as indigo, quinic acid and catechol
[18,19]. L-Tryptophan is primarily used as a feed and food
additive, and has other pharmaceutical applications [20]. The
estimated production rate of L-Tryptophan is 500 ton/year [21].
L-Phenylalanine is primarily used for the production of the
artificial sweetener aspartame [20,22], and as a nutraceutical, a
flavor enhancer, and an intermediate for pharmaceutical produc-
tion [20], with an estimated production of 8,000 ton/year [21]. L-
Tyrosine is used in the production of the anti-Parkinson’s drug L-
DOPA, and as a dietary supplement [20], and is produced at a
smaller scale of about 120 ton/year [21].
In E. coli and many other organisms, the production of aromatic
compounds begins with the condensation reaction between
phosphoenolpyruvate (PEP) and erythrose-4-phosphate (E4P) to
form 3-deoxy-D-arabinoheptulosonate-7-phosphate (DAHP). This
reaction, catalyzed by DAHP synthase (AroG), is the committed
step and the most tightly regulated reaction in the common
aromatic amino acid pathway [20]. DAHP has often been used as
an index for the capability of aromatics production [19,22–27].
We choose the production of aromatic amino acids in Escherichia
coli as a system to demonstrate the applicability of EM because this
system is an example of both kinetic and stoichiometric limitations
that takes place in metabolic systems. Stoichiometric analysis
shows that the theoretical yield of DAHP production from glucose
in the wildtype E. coli is 43% (mol/mol) [19,22]. This relatively low
theoretical yield is due to the fact that E. coli cannot recycle
pyruvate back to PEP during glycolytic growth. Thus, when PEP is
converted to pyruvate during glucose transport via the phospho-
transferase system (PTS), the pyruvate generated cannot be used in
the aromatic synthesis, causing a decrease in yield. In order to
increase the yield, either pyruvate has to be recycled back to PEP
via PEP synthase (Pps) [22], or use a PEP-independent glucose
transport system [19,25]. Once pyruvate is recycled or a PEP-
independent transport system is used, the theoretical yield
increased to 86% (mol/mol). However, when Pps is overepressed
in E. coli, there is no change in DAHP yield. On the other hand,
overexpression of Tkt effectively increases the yield to close to
43%. Overexpression of both Pps and Tkt then increases the yield
to 86%, approaching the theoretical limit [19,22]. This example
indicates that Tkt is the first limiting enzyme. Once this bottleneck
is removed, then Pps can demonstrate its effect. This type of
kinetic behavior cannot be captured using either stoichiometric
models or a direct flux comparison between flux states.
Here we use EM to study the production of DAHP from glucose
in E.coli, utilizing existing data from the literature to screen the
ensemble of models. By using data that has been reported for the
overexpression of transketolase (Tkt), transaldolase (Tal) and
Figure 1. The elementary reaction mechanisms. Mechanisms used for the variety of different metabolic reactions. Reactions modeled as 1
substrate to 1 product: HPr, EIIA, Pgi, Tpi, Gpm, Eno, Pgl, Rpe, Rpi, Pta, Ppc, Fum, Sdh, recycle reactions of ATP, NADH and NADPH. 2 substrate to 1
product reactions: EIIBC, AroG
fbr. 1 substrate to 2 products: EI, Fba, Pfl. 2 substrates to 2 products: Pfk, Gap, Pgk, Zwf, Gnd, Tkt, Tal, Pyk, Pps, Ack, Mdh.
doi:10.1371/journal.pone.0006903.g001
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ensemble of models to a subset that accurately describes the kinetic
phenomena that is at work in this system. The final screened
ensemble of models demonstrates the property that the E4P
metabolite pool is initially limiting, and only after this limitation is
lifted, does the PEP pool become important. Thus, we can correctly
predict that only after Tkt is overexpressed does the overexpression
of Pps play a role in an increased rate of DAHP production. This
work thus demonstrates that EM is able to capture properties of
metabolic networks in a real biological system through the
utilization of enzyme tuning data to drive model development.
Results
The DAHP Metabolic Network
The metabolic network for the production of DAHP is depicted
in Figure 3. This network includes the PTS for glucose uptake,
glycolysis pathway, pentose phosphate pathway, Krebs cycle, the
formate and acetate production pathways, and the pathway for the
synthesis of DAHP. The PTS is modeled as a series of
phosphorylation steps [11]. First, enzyme I (EI) uses PEP as the
phosphoryl donor, thus converting PEP to pyruvate and
phosphorylating histidine protein (HPr). Next, HPr phosphorylates
enzyme IIA (EIIA), which in turn phoshorylates enzyme IIBC
(EIIBC). Finally, in the last step, EIIBC transfers the phosphate to
glucose, thus converting the glucose to glucose-6-phosphate (G6P).
Further, phosphofructokinase (Pfk) is feedback inhibited by
phosphoenolpyruvate (PEP). This network consists of 37 net
reactions and 34 metabolites. The full list of abbreviations used in
this network can be found in Table 1.
Obtaining Steady State Fluxes
For the production of DAHP, the external fluxes of the system
(glucose uptake and the secretion of DAHP, succinate, acetate and
formate) have been reported [19]. However, it can be seen that
even when the external fluxes are determined, there is an
additional degree of freedom at the metabolite glucose-6-
phosphate (G6P), where the flux coming into the system is split
between glycolysis (via Pgi) and the pentose phosphate pathway
(via Zwf). To account for this additional degree of freedom in
determining the steady state flux, we calculate the flux map for a
variety of glycolysis:pentose phosphate pathway split ratios (25:75,
50:50, 75:25 and 95:5) and carry out the EM approach using each
of these varying flux maps to examine the effect of the split ratio on
the modeling results. In addition, recycle reactions are included to
allow the cell to dispose of extra energy (ATP) or reducing power
(NADH, NADPH). Each of the steady state fluxes for the various
split ratios are reported in Table 2.
Construction of the Initial Ensemble
For each glycolysis:pentose pathway split ratio, an ensemble of
1500 models was constructed using Matlab (Mathworks, Natick,
MA) on an Intel (Santa Clara, CA) Pentium 4 processor running
Figure 2. Algorithm for Ensemble Modeling. The algorithm is illustrated on the left, while the steps are described in detail on the right.
doi:10.1371/journal.pone.0006903.g002
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time to develop and perturb each ensemble to obtain the
overexpression phenotypes of interest was approximately
18 hours. In addition to the steady state fluxes, the other input
into the algorithm is the standard Gibbs free energies for each
reaction, which are listed in Table 3. The reactions are then
broken down into their elementary steps, as described in Methods.
The way that each reaction in the network is modeled is described
in Figure 1. The reversibilities for each elementary step are
sampled uniformly from zero to one, and the thermodynamic
compliance of the reaction is checked using Eq. (13). If the
reversibilities are determined to be outside the constraints imposed
by thermodynamics, they are resampled. The enzyme fractions for
each set of elementary reactions are uniformly sampled from zero
to one, and each of the fractions relating to enzyme i are rescaled
such that there sum is equal to one.
Perturbation and Screening of the Ensemble
In our system of interest for the production of DAHP, an
important metabolic kinetic phenomenon is at work. The
Figure 3. The metabolic network for the production of aromatic precursor 3-deoxy-D-arabino-heptulosonate-7-phosphate (DAHP).
Metabolites are denoted by capital letters, while enzyme abbreviations are in italics. The metabolite PEP feedback inhibits the enzyme
phosphofructokinase (pfk). In the studied system, 2-dehydro-3-deoxyphosphoheptonate aldolase (aroG) had already been made feedback resistant,
denoted by superscript ‘‘fbr’’.
doi:10.1371/journal.pone.0006903.g003
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and E4P, from different areas of the metabolic network. Thus,
how these pools are balanced, a kinetic property, is the key to
increased DAHP production. It has been demonstrated that the
E4P metabolite pool is the limiting metabolite in DAHP
synthesis, and that only after this limitation is lifted do
perturbations in enzyme levels that increase the PEP pool size
yield an increase in production. It has been reported that the
overexpression of Tkt [19,22–26] and Tal [27], which increase
the E4P pool, lead to an increase in the DAHP production rate
and yield from glucose. While the overexpression of both of these
enzymes increased the production rate, it was found that
overexpression of Tkt had a stronger effect than the overexpres-
sion of Tal [27]. Further, the overexpression of Tkt shows a
negligible impact on the glucose uptake rate [19,22,26]. The
overexpression of Pps alone, which would increase the PEP pool,
had no effect on DAHP production [22]. However, when both
Tkt and Pps were overexpressed simultaneously, the combined
effect of these overexpressions was far greater than the single
overexpression of either Tkt or Pps [22,26]. All of the phenotypes
are summarized in Table 4.
After constructing the ensemble of models for each of the split
ratios, each model was perturbed by overexpressing Tkt, Tal and
Pps two-fold, one at a time. After perturbation of the ensemble, the
models that did not match the literature phenotypes were screened
out of the ensemble. For the phenotypes where overexpression led
Table 1. Abbreviations for metabolites and enzymes.
Metabolite Name Metabolite Symbol Enzyme Name Enzyme Symbol
2-phosphoglycerate 2PG acetate transport acetate_out
3-phosphoglycerate 3PG acetate kinase ack
acetyl-CoA ACCOA 2-dehydro-3-deoxyphosphoheptonate aldolase aroG
acetate ACETATE DAHP transport dahp_out
acetyl phosphate ACP enzyme I EI
adenosine diphosphate ADP enzyme IIA EIIA
adenosine triphosphate ATP enzyme IIBC EIIBC
3-deoxy-D-arabino-heptulosonate-7-phosphate DAHP enolase eno
dihydroxy acetone phosphate DHAP fructose biphosphate aldolase fba
1,3-biphosphoglycerate DPG formate transport formate_out
erythrose-4-phosphate E4P fumarase fum
fructose-6-phosphate F6P glyceraldehyde 3-phosphate dehydrogenase gap
fructose-1,6-biphosphate FDP 6-phosphogluconate dehydrogenase gnd
formate FORMATE phosphoglycerate mutase gpm
fumarate FUM histidine protein HPr
glucose-6-phosphate G6P malate dehydrogenase mdh
glyceraldehyde-3-phosphate GAP phosphofructokinase pfk
b-D-glucose GLUCOSE pyruvate formate lyase pfl
malate MAL phosphogluco isomerase pgi
nicotinamide adenine dinucleotide NAD phosphoglycerate kinase pgk
nicotinamide adenine dinucleotide reduced NADH 6-phosphogluconolactonase pgl
nicotinamide adenine dinucleotide phosphate NADP phosphoenolpyruvate carboxylase ppc
nicotinamide adenine dinucleotide phosphate reduced NADPH phosphoenolpyruvate synthase pps
oxaloacetate OAA phosphate acetyltransferase pta
phosphate group P phosphotransferase system pts
phosphoenolpyruvate PEP pyruvate kinase pyk
6-phosphogluconolactone PGL ATP recycle recATP
6-phosphogluconate PGT NADH recycle recNADH
pyruvate PYR NADPH recycle recNADPH
ribose-5-phosphate R5P ribulose-5-phosphate 3-epimerase rpe
ribulose-5-phosphate Ru5P ribulose-5-phosphate isomerase rpi
sedoheptulose-7-phosphate S7P succinate dehydrogenase sdh
succinate SUCCINATE succinate transport succinate_out
xylulose-5-phosphate X5P transaldolase tal
transketolase tkt
triose phosphate isomerase tpi
glucose-6-phosphate dehydrogenase zwf
doi:10.1371/journal.pone.0006903.t001
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exhibited any increase in the DAHP production rate were kept.
For the phenotype of Pps overexpression leading to no change in
the DAHP rate, only models that did not exceed an increase or
decrease of 10% of the maximum DAHP rate increase for that
ensemble were kept. For the glucose uptake rate being unchanged
with Tkt overexpression, only models that exhibited less than a
10% change in the glucose uptake rate were retained. To screen
for Tkt overexpression increasing the DAHP rate more than Tal
overexpression, only models where the DAHP rate when Tkt is
overexpressed was greater than the DAHP rate when Tal was
overexpressed were retained.
The results of the screening are illustrated in Figure 4.I n
screening for the overexpression of Tkt leading to an increase in the
DAHP production rate, 122, 90, 575 and 534 models were retained
for the 25:75, 50:50, 75:25 and 95:5 split ratios, respectively. From
this reduced subset of models, screening for those in which Tal
overexpression also leads to an increase in the DAHP production,
led to the retention of 70, 42, 525, and 512 models for the 25:75,
50:50, 75:25 and 95:5 split ratios, respectively. It should be noted
that higher fractions of models are retained in each successive step.
This result suggests that the ensemble becomes more and more
predictive. Ideally, when the model is truly predictive, 100% of the
ensemble will be retained between screening steps and the
Table 2. Net flux (mmol/g DCW/hr) of reference state for
various glycolysis vs pentose pathway split ratios.
Glycolysis:Pentose Split 25:75 50:50 75:25 95:5
acetate_out 1.408 1.517 1.625 1.712
ack 1.408 1.517 1.625 1.712
aroG 0.260 0.260 0.260 0.260
dahp_out 0.260 0.260 0.260 0.260
EI 1.300 1.300 1.300 1.300
EIIA 1.300 1.300 1.300 1.300
EIIBC 1.300 1.300 1.300 1.300
eno 1.928 2.037 2.145 2.232
fba 0.888 0.997 1.105 1.192
formate_out 1.408 1.517 1.625 1.712
fum 0.260 0.260 0.260 0.260
gap 1.928 2.037 2.145 2.232
gnd 0.975 0.650 0.325 0.065
gpm 1.928 2.037 2.145 2.232
HPr 1.300 1.300 1.300 1.300
mdh 0.260 0.260 0.260 0.260
pfk 0.888 0.997 1.105 1.192
pfl 1.408 1.517 1.625 1.712
pgi 0.325 0.650 0.975 1.235
pgk 1.928 2.037 2.145 2.232
pgl 0.975 0.650 0.325 0.065
ppc 0.260 0.260 0.260 0.260
pps 0.006 0.011 0.017 0.022
pta 1.408 1.517 1.625 1.712
pyk 0.114 0.228 0.342 0.433
recATP 2.557 2.773 2.990 3.163
recNADH 1.668 1.777 1.885 1.972
recNADPH 1.950 1.300 0.650 0.130
rpe 0.563 0.347 0.130 20.043
rpi 0.412 0.303 0.195 0.108
sdh 0.260 0.260 0.260 0.260
succinate_out 0.260 0.260 0.260 0.260
tal 0.412 0.303 0.195 0.108
tkt (1) 0.412 0.303 0.195 0.108
tkt (2) 0.152 0.043 20.065 20.152
tpi 0.888 0.997 1.105 1.192
zwf 0.975 0.650 0.325 0.065
doi:10.1371/journal.pone.0006903.t002
Table 3. Overall reactions and free energies.
Reaction Overall Equation Inhibitor
Free Energy
(kcal/mol)
acetate_out ACETATE --.out – 23.5
ack ACP+ADP --. ACETATE+ATP – 24.7
aroG PEP+E4P --. DAHP – 217.9
dahp_out DAHP --. out – 23.5
EI PEP --. PYR+P– 26.45
EIIA P- - . P– 20.1
EIIBC P+GLUCOSE --. G6P – 26.45
eno 2PG --. PEP – 20.2
fba FDP --. DHAP+GAP – 1.1
formate_out FORMATE --. out – 23.5
fum MAL --. FUM – 1.3
gap GAP+NAD --. DPG+NADH – 4.2
gnd PGT+NADP --. Ru5P+NADPH – 20.8
gpm 3PG --. 2PG – 22.2
HPr P- - . P– 20.1
mdh OAA+NADH --. MAL+NAD – 24.8
pfk F6P+ATP --. FDP+ADP PEP 24.5
pfl PYR --. FORMATE+ACCOA – 22.5
pgi G6P --. F6P – 22.5
pgk DPG+ADP --. 3PG+ATP – 4.7
pgl PGL --. PGT – 213.3
ppc PEP --. OAA – 211.7
pps PYR+ATP --. PEP+ADP – 23.6
pta ACCOA --. ACP – 23.9
pyk PEP+ADP --. PYR+ATP – 28.4
recATP ATP --. ADP – 20.1
recNADH NADH --. NAD – 20.1
recNADPH NADPH --. NADP – 20.1
rpe Ru5P --. X5P – 20.1
rpi Ru5P --. R5P – 0.7
sdh FUM --. SUCCINATE – 20.7
succinate_out SUCCINATE --. out – 23.5
tal S7P+GAP --. F6P+E4P – 20.6
tkt (1) X5P+R5P --. S7P+GAP – 0.9
tkt (2) X5P+E4P --. F6P+GAP – 20.6
tpi DHAP --. GAP – 0.2
zwf G6P+NADP --. PGL+NADPH – 20.9
doi:10.1371/journal.pone.0006903.t003
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Figs. 4C & 4D illustrate this phenomenon. On the other hand,
when no model is retained after screening, at least one of the
underlying assumptions is invalid. This phenomenon is illustrated in
Figs. 4A & 4B, where incorrect glycolysis:pentose pathway split
ratios gave no acceptable model.
While we are screening from the previously determined subset,
each of the perturbations was done in parallel, not sequentially.
Table 4. Summary of literature used for screening phenotypes.
Target Gene(s) Phenotype Reference
transketolase (tkt) tkt overexpression increases DAHP production rate Draths et al. (1992), Flores et al. (1996), Gosset et al. (1996), Baez et al. (2001)
transketolase (tkt) tkt overexpression has no change on glucose uptake Patnaik & Liao (1994), Patnaik et al. (1995), Gosset et al. (1996)
transaldolase (tal) tal overexpression increases DAHP production rate Lu & Liao (1997)
phosphoenolpyruvate
synthase (pps)
pps overexpression has no change on DAHP production
rate
Patnaik & Liao (1994)
tkt & tal tkt overexpression gives a larger increase than tal
overexpression
Lu & Liao (1997)
tkt & pps tkt & pps simultaneous overexpression increases DAHP
production rate
Patnaik & Liao (1994), Gosset et al. (1996)
doi:10.1371/journal.pone.0006903.t004
Figure 4. Results of screening for each of the reported literature phenotypes. Screening of phenotypes from Table 4, using each of the four
glycolysis:pentose phosphate pathway split ratios. For the two fluxes with the highest proportion of the flux through the pentose-phosphate
pathway (panels A&B), zero models in the ensemble were able to match all of the experimental phenotypes. For the two flux distributions with the
highest flux through glycolysis (panels C&D), approximately one-tenth of the original ensemble matched each of the screening phenotypes. The size
of each column represents the number of models remaining after the screening step indicated on the x-axis.
doi:10.1371/journal.pone.0006903.g004
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independently, and the models common to both screens could be
retained. Further, the order in which the models are screened does
not influence the final number of models that matches all
phenotypes. When the phenotypes are observed relative to the
same reference state (i.e. done in parallel), they can all be viewed
independently, and the models retained after screening can be
illustrated as the intersection between each phenotype, as
demonstrated in Figure 5.
From the reduced subset matching the Tkt and Tal phenotypes,
screening for Pps overexpression leading to no change in DAHP
production results in 8, 0, 318 and 278 models matching the
phenotype for each of the split ratios. Of these models, the number
that exhibited the property that the glucose uptake rate did not change
when Tkt was overexpressed reduced the size of the ensembles to
7, 0, 241 and 235 models, in order of increasing glycolytic flux.
The final literature observation used for screening is that of an
increase in DAHP production via Tkt overexpression being
greater than the increase observed from Tal overexpression. This
led to a final ensemble size of 171 and 195 models for the 75:25
and 95:5 split ratios, respectively (Figs. 4C & 4D). For the split
ratios with a higher percentage of the flux through the pentose-
phosphate pathway (Fig. 4A & 4B), zero of the models in the
original ensemble remained after all of the screening steps. In fact,
no models remained after just three screening steps when the flux
was split 50:50 between glycolysis and the pentose pathway. This
indicates that in the EM approach, just as in nature, the effect of
enzyme overexpression is dependent on the reference flux
distribution. Further, this demonstrates that in the true system,
the reference steady state flux may indeed have the majority of the
metabolic flux directed through glycolysis, which follows the
experimental observation that the overexpression of Tkt is
limiting, as the Tkt net flux only becomes negative (thus feeding,
not draining, the E4P pool) when the split ratio is 60:40 or greater.
Prediction of Tkt/Pps Dual Overexpression
To determine whether the screened ensemble of models
becomes increasingly predictive, we test the behavior of the
remaining models when both Tkt and Pps are simultaneously
overexpressed two-fold. Indeed, even though these subsets of the
original ensemble demonstrate that the sole overexpression of Pps
has no effect on the DAHP steady state production rate, when Pps
is overexpressed simultaneously with Tkt, 100% of the models for
both the 75:25 and 95:5 split ratios yield an increase in the DAHP
rate that is greater than the sum of the single overexpressions of
Tkt and Pps, as shown in Figure 6A.
Since PEP is used in glucose transport via the PTS to form
pyruvate, most carbon is not used in aromatics biosynthesis, resulting
in a low yield. This problem was identified previously [22] and two
solutions were developed. The first is recycling pyruvate back to PEP
via overexpression of Pps, and the second is the use of non-PTS genes
for glucose transport [25]. Interestingly, relieving this stoichiometric
limitation did not increase the yield of DAHP until transketolase (the
product of the tktA gene) was overexpressed [22,26]. Apparently, a
kinetic limitation caused by Tkt is the first bottleneck for DAHP
production. Such behavior cannot be predicted using either
stoichiometric models or a direct flux comparison between flux
states. However, the EM approach was able to reproduce this
phenomenon, which is illustrated in Figure 6B.
Properties of Screened Models
For the final ensembles of 171 and 195 models for the split
ratios of 75:25 and 95:5, respectively, the sampled parameters of
these screened subsets were examined to determine what
Figure 5. Illustration of screening the ensemble of models using different literature phenotypes. Because the ensemble is being
screened using the effect of different enzyme overexpressions on the same reference state, the final screened ensemble is independent of the path
chosen, and can be represented by the intersection of the subsets screened by each phenotype. For demonstration, the results of screening for the
reference flux with a glycolysis:pentose phosphate pathway split ratio of 75:25 are shown. The values indicate how many of the original ensemble of
n=1500 models match the given phenotype.
doi:10.1371/journal.pone.0006903.g005
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ensemble of models. The enzyme fractions of each free enzyme
(enzyme not in a complex), and the net reversibilities of each
overall reaction were examined to determine how their distribu-
tions for the screened models deviated from the original ensemble.
For each parameter of interest, a two-sample Kolmogorov-
Smirnov test [28] was conducted to determine if the distribution
of that parameter within the screened models exhibited a
significantly shifted distribution (with 95% confidence) when
compared to the original ensemble of 1500 models. Examples of
these distributions can be seen in Figure 7.
For both flux states examined, it was found that three of the
enzymes showed a significant deviation in their distributions
relative to the original ensemble, and none of the reaction
reversibilities exhibited a deviation. For both flux states, the free
enzyme fractions of enzyme I (EI), pyruvate kinase (Pyk), and
phosphoenolpyruvate carboxylase (Ppc) had a significantly differ-
ent parameter distribution compared to the original ensemble.
Figure 7A demonstrates the change in the distribution of the EI
free enzyme fraction for the 95:5 split ratio. Each of these three
identified enzymes share the metabolite phosphoenolpyruvate
(PEP) as a reactant, which is also involved in the condensation
reaction to form our desired product DAHP. Biologically, in the
case of EI, the relatively low free enzyme fraction in the selected
models indicates that glucose uptake is essentially saturated, and
that a change in the concentrations of substrates of this reaction
Figure 6. Dual overexpression kinetic phenomena for DAHP production. A) Illustration of the prediction for the dual overexpression of Tkt
and Pps for the split ratio of 95:5. 100% of the selected models exhibit the phenotype where when Tkt and Pps are simultaneously overexpressed, the
combined effect is greater than the sum of the two individual overexpressions. B) The kinetic phenomenon in DAHP production illustrated. Pps
overexpression does not increase DAHP production until Tkt is overexpressed. After removing this limitation, Pps overexpression has a dramatic
effect on DAHP production, pushing yields near the theoretical limit of 86% mol DAHP/mol glucose.
doi:10.1371/journal.pone.0006903.g006
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pression of Pps) would have little effect on changing the system.
After determining that these three parameters were significantly
distributed in the screened models, a hierarchical clustering
analysis was performed examining these three free enzyme
fractions in the original ensemble of models for the 95:5
glycolysis:pentose pathway split, as shown in Figure 7B. The
models which were eventually to be selected from this ensemble
existed in primarily two distinct clusters. To determine the
differences between the models within these two clusters, the
distribution of the parameter values in each individual cluster was
calculated, and compared to the original ensemble (Fig. 7C).
While both clusters show a similar distribution for the EI free
enzyme fraction, the two clusters demonstrate significant differ-
ences when the Pyk and Ppc free enzyme fractions are compared.
The Pyk free enzyme fraction of cluster 1 deviates from both the
original ensemble and cluster 2, as cluster 1 has a higher
proportion of the Pyk enzyme in its free form. The Ppc free
enzyme fraction for cluster 2 is higher than both the original
ensemble and cluster 1. Each of these enzymes reacts to form a
complex with PEP, and thus by having a higher fraction in the free
enzyme form, would leave more PEP free, keeping this metabolite
from becoming limiting, and allowing these models to match the
experimental phenotype indicating that E4P, and not PEP, is the
first limiting metabolite in DAHP synthesis. Thus, there exist two
alternative routes to match the experimentally observed pheno-
types. Relatively high free enzyme fractions of Pyk and Ppc seem
to act as alternative methods to achieve the observed phenotypes.
If the free enzyme fractions of Pyk and Ppc are too low, much of
the PEP concentration will be trapped in complex with the
enzyme, and the PEP pool will become limiting. Further, if these
two reactions have low free enzyme fractions, they are essentially
saturated, and thus when Pps is overexpressed, there would be an
increase in the PEP pool that would necessarily lead to an increase
in DAHP production, as there would be no other alternative
pathways to consume the increase in PEP.
Spanning the Kinetic Space
To determine if the construction of 1500 models in the original
ensemble was enough to adequately cover the range of possible
kinetics, and thus yield screening results which were reproducible,
the ensemble construction and screening process for the 95:5 split
Figure 7. Analysis of parameters in screened models relative to original ensemble. Parameter analysis for the glycolysis:pentose
phosphate pathway split ratio of 95:5. A) The distribution of the enzyme fraction representing the free enzyme EI for the original ensemble (solid line)
compared to the final screened ensemble of n=195 models (dashed line). B) Hierarchical clustering by the sampled enzyme fractions indicates that
the screened models (denoted by black bars) exist primarily in two distinct clusters. C) The distribution of enzyme fractions representing the free
enzymes EI, Pyk & Ppc for each of the two clusters (dashed lines) relative to the original ensemble (solid line). Both clusters have distributions in EI
that deviate significantly from the original ensemble. Only cluster 1 has a distribution for Pyk significantly different from the original ensemble, and
only cluster 2 has a Ppc distribution that deviates from the original ensemble.
doi:10.1371/journal.pone.0006903.g007
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results. From an initial ensemble of 1500 models for each of the
three ensembles, both the final number of models retained after all
screening steps, and the models retained after each individual step
variedless than 10%from repeatto repeat,shown inFigure8. The
final ensemble of models for the 95:5 split ratio for each of the three
repeats was 195, 207, and 212 models, indicating that the
construction of 1500 models adequately covers the kinetic space.
Discussion
In this work, we used the EM approach [11] to model the
production of aromatic precursor DAHP production in E. coli.T h e
difficulty in developing kinetic models for metabolic systems is well
recognized, and is due to a lack of kinetic parameters. In this work,
rather than attempting to construct a traditional kinetic model that
matches dynamic metabolite concentration data and facing the issue
of kinetic parameter identification, we focused on utilizing enzyme
overexpression phenotype data, which are plentiful and relatively
straightforward to acquire, to screen models. The EM approach is
used to construct an ensemble of models for four different flux
distributions, which are then screened using enzyme overexpression
data from the literature. We show that in five screening steps, the
ensembles can converge to a set of models which becomes predictive.
Since the entire flux map is not known, but only the external
fluxes have been measured, a variety of split ratios were examined
between glycolysis and the pentose phosphate pathway. The E4P
metabolite pool is fed by transketolase (Tkt) ‘‘running backwards’’
from glycolysis, thus supporting the literature phenotypes only
when the fraction of the carbon flux through glycolysis is above
60%. Interestingly, the EM approach was able to identify this
property, as neither of the flux maps with less than a 60:40 split
ratio were able to retain any models that matched each of the
screening phenotypes. However, many models were retained for
each of the two flux distributions with greater than a 60:40 split
ratio. This indicates that a general idea of the flux distribution
could be reverse engineered through the use of enzyme
overexpression phenotypes and EM.
As one looks at the advantages and challenges of such an
approach, it can be seen that for complicated networks with many
pathways that lead to the external fluxes, there may be many
degrees of freedom in determining the steady state flux, and thus the
determination of the reference flux (the algorithm’s primary input)
may limit the possible systems to be studied. The iterative screening
approach demonstrated here allows for the rapid collaboration and
iteration between experiment and computation. As demonstrated
for DAHP production, any enzyme overexpression phenotype can
be used as a step in screening the ensemble, makingall experimental
data potentially useful, whether the data shows an increase in the
production rateofinterest,a decrease,ornochangeat all. Whilethe
predictive capabilities of the EM approach are primarily qualitative,
this provides a tool to drive experimentation and to learn from the
results. If a prediction is proven to be incorrect, this information can
also be incorporated into the screening, allowing for the formation
of an alternate hypothesis.
In using reported enzyme overexpression data for Tkt, Tal and
Pps, it is demonstrated that the screened set of models exhibits the
kinetic phenomena that is at work in the network, without the
need for kinetic parameters. The final screened ensemble of
models shows that Tkt is the first limiting step, and correctly
predicts that only after this limitation is lifted does an increase in
Pps increase the production rate of DAHP. This work thus
demonstrates that EM is able to capture kinetic properties of
metabolic networks by utilizing enzyme tuning data to refine and
screen the ensemble.
Methods
Obtaining Steady State Fluxes
The first step in EM is to obtain the steady-state fluxes in the
reference state of interest. The reference state is typically the base-
line control strain before further metabolic engineering. In order
to model a given steady state, the flux distribution of that state
must first be determined. This flux distribution, or flux map, can
be deduced via a variety of methods. Typically, the external fluxes
of the system may be known, or easily measureable using GC or
HPLC. In this case, the internal fluxes of the system can be









This can be represented for the entire network in matrix form:
S:v~0 ð2Þ
where the matrix S is the m x n stoichiometric matrix consisting of
m metabolites and n net reactions, and v is the n x 1 vector of net
reaction rates. For more detailed analysis, the full flux map may be
determined through the use of C13 isotopomer analysis [29–33],
which involves feeding the cells a precisely labeled mix of glucose.
However, such detailed analyses are not necessary in the first step.
Model Building Using Elementary Reactions
At the molecular level, the basic elementary reactions (either bi-
molecular or uni-molecular) that follow mass-action kinetics are the
most fundamental kinetic events [6]. An elementary reaction is a
Figure 8. Repeatability of Ensemble Modeling. Three repeats of
1500 models in each ensemble for a 95:5 split ratio show very similar
models retained after each screening step. Less than 10% variance in
the number of models retained is observed at each screening step, with
each ensemble selecting out 195, 212, and 207 models, respectively,
after all screening.
doi:10.1371/journal.pone.0006903.g008
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react directly to form products in a single reaction step and with a
single transition state. These reactions follow mass action kinetics.
Free enzymes and enzyme-substrate complexes are treated as
separate chemical species as either reactants or products. The
elementary reactions are the basis for deriving lumped enzyme
kinetic rate laws such as Michaelis-Menten kinetics and more
complicated allosteric regulation kinetics. Because of total enzyme
conservation, the elementary reactions automatically give rise to a
saturation behavior characteristic in biological reactions. Regulato-
ry mechanisms are also broken down in terms of elementary
reactions. In the EM approach, each enzymatic reaction is broken
down into a series of elementary reactions, thus preserving the
fundamental behavior we know to exist in metabolic networks. The
mechanism that is used for the various metabolic reactions in this
work is depicted in Figure 1, for various combinations of reactants
and products. The PTS is modeled as a series of phosphorylation
steps [11]. For modeling purposes, each of the phosphorylated
enzymes is considered to be a substrate or reaction product, while
each of the free enzymes is considered to be the enzyme that
participates in the reaction. Thus, for the entire PTS, each enzyme
drives a step of the reaction and is then regenerated in the
subsequent phosphorylation step. Also demonstrated in Figure 1 is
how regulatory steps can be easily included into the framework.
The general form for the elementary reactions in an enzymatic
reaction of one substrate to one product can be depicted as follows:
XizEi / { { ?
vi,1
vi,2
XiEi / { { ?
vi,3
vi,4




step 1 step 2 step 3
where the rate of each individual elementary reaction, vi,k, follows
the mass action principle:
vi,1~ki,1 Xi ½  Ei ½  ð 3Þ
where ki,1 is the rate constant of the forward reaction of step 1 of
the overall reaction catalyzed by the enzyme i, Xi ½  is the
concentration of metabolite i, and Ei ½  is the concentration of free
enzyme i. To avoid quantifying the absolute concentrations of
each metabolite and enzyme, we scale their concentrations by the




i,1 :~ X Xi:~ e ei,1 ð4Þ
where ~ K K
ref








ss,refequal to the metabolite’s concentration at steady state,
and E
ref
i,total the total concentration of the corresponding enzyme at
the reference state. Note that the rate law in Eq. (4) has the log-
linear form:
ln vi,1~ln ~ K K
ref
i,1 zln ~ X Xizln ~ e ei,1, ð6Þ
Each of the transport reactions out of the system are modeled
with mass-action kinetics:
v~K:x ð7Þ
For the reference state, ln ~ X Xi~0, and ~ K K
ref
i,1 can be calculated
from Eq. (6) after the uni-directional flux vi,1 and enzyme fraction
~ e ei,1 are determined. The uni-directional flux vi,1 is determined
from the sampled reversibility (see next section), and the enzyme
fraction ~ e ei,1 is sampled directly (see next section).
The Ensemble Modeling (EM) Sampling Algorithm
The EM methodology is illustrated in Figure 2. The inputs into
the algorithm are the steady state flux distribution of the reference
state and the Gibbs free energies of the reactions, which allow for
the assignment of thermodynamic constraints on the system. The
reference steady state fluxes are obtained as described above, while
the range of Gibbs free energies are calculated from the standard
Gibbs free energies [34] allowing for a one-hundred fold change in
metabolite concentrations.
In the first sampling step, the reversibilities for each elementary
step Ri,j are sampled. These reversibilities can be related to the












   ð9Þ
where V
ref
i,net is the net flux of the reaction i at the reference steady
state, and vi,2j{1 and vi,2j are the forward and backward rates of
step j in reaction i. The reversibilities range from 0 (for an
irreversible step) to 1 (for a step at equilibrium). Thus, the forward
and backward rates can be calculated from the reversibility and





























where sign(Vi,net) represents the direction of the net flux (positive if
forward and negative if backwards). The reversibilities are








where ni represents the number of elementary steps for enzyme i.
This requiresthat the net flux of reaction i be positiveif DGiv0,a n d
negative if DGiw0. This constraint is used to check if the reference
steady-state is thermodynamically compliant. Since the exact values
for the Gibb free energies are not known, but their ranges can be
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steps, the net reaction, and the free energy bounds has been
previously derived [11].
Next, the enzyme fractions are sampled. The enzyme fractions
are the fractions of the total enzyme amount that exist as the free
enzyme and as the various enzyme complexes at steady state, such
that the sum of all the fractions are equal to one, conserving the






At the reference steady state ~ X Xi~1 and Eq. (6) becomes:
lnv
ref
i,1 ~ln ~ K K
ref
i,1 zln~ e e
ref
i,1 ð15Þ
Once this sampling of enzyme fractions is complete, the kinetic
parameters for that model can be assigned. The kinetic parameters
~ K K
ref
i,k can be easily computed from Eq. (15), as v
ref
i,1 is determined




Establish the Ensemble of Models
Next the ordinary differential equations (ODEs) governing the
system are solved at the reference state. The network can be
described by a system of ODEs and solved numerically, where the
metabolite concentrations and enzyme fractions, not the total
enzyme concentrations, are the ODE variables:






























where the superscript ‘‘0’’ represents the initial condition of the
enzyme fractions.
Different combinations of reversibilities represent different









Every model reaches the same steady state, and the reversibil-
ities R
ref
k (which represents the vector composed of the
reversibilities for each elementary step) and enzyme fractions
e
ref
k (which represents the vector composed of the enzyme fractions
for each free enzyme and enzyme complex) are reassigned for each
subsequent model. This allows for the formation of an ensemble of
models that span the range of kinetics allowable by thermody-
namics.
Screening of the Models by Perturbation
The entire ensemble can be perturbed to determine each
individual model’s response to the enzyme expression perturbation
with which we would like to screen the ensemble. In order to
perturb the concentration of an enzyme for an individual model in
the ensemble, Eq. (4) is modified:
vi,1~~ K K
ref
i,1 :Ei,r:~ X Xi:~ e ei,1 ð20Þ
The additional variable Ei,r represents the fold change in total
enzyme concentration relative to the reference state. Each enzyme
of interest is overexpressed n-fold (Ei,r=n) to determine its effect on
production. Here we use n=2. If the metabolic network contains
any moiety conservation relationships [37], the initial conditions
are set such that the sum of these metabolite remain unchanged.
For example, the sum of cofactors and their intermediates in the
new perturbed condition must be equal to those in reference
steady state.
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